Review
Cardiac & Cardiovascular Systems
Iona Cuthbertson, Nicholas W. Morrell, Paola Caruso
Summary: Pulmonary arterial hypertension (PAH) is the most severe type of pulmonary hypertension, characterized by progressive remodeling of peripheral pulmonary arteries. Endothelial cell dysfunction is a key trigger, leading to vascular remodeling, increased pressure, and right ventricular hypertrophy. Abnormal cellular molecular signatures and loss-of-function mutations in the BMPR2 gene contribute to PAH pathophysiology. Metabolic abnormalities, including glycolytic reprogramming and mitochondrial dysfunction, are observed in various tissues and may affect treatment response. This review critically discusses the mechanisms linking metabolic abnormalities with dysfunctional BMPR2 signaling and their relevance to PAH pathogenesis and potential therapies.
CIRCULATION RESEARCH
(2023)
Article
Multidisciplinary Sciences
Aneel R. Bhagwani, Mehboob Ali, Bryce Piper, Mingjun Liu, Jaylen Hudson, Neil Kelly, Srimathi Bogamuwa, Hu Yang, James D. Londino, Joseph S. Bednash, Daniela Farkas, Rama K. Mallampalli, Mark R. Nicolls, John J. Ryan, A. A. Roger Thompson, Stephen Y. Chan, Delphine Gomez, Elena A. Goncharova, Laszlo Farkas
Summary: Pulmonary arterial hypertension (PAH) is characterized by pathogenic and abnormal endothelial cells (ECs), potentially resulting from clonal selection. This study explores the role of p53 and toll-like receptor 3 (TLR3) in clonal expansion and pulmonary hypertension (PH) through regulation of bone morphogenetic protein (BMPR2) signaling. The findings suggest that a p53/TLR3/IRF3 axis regulates BMPR2 expression and signaling in ECs, offering a potential therapeutic target for PH.
Article
Peripheral Vascular Disease
L. Rhiannon Hilton, Matthew T. Ratsep, M. Martin VandenBroek, Salema Jafri, Kimberly J. Laverty, Melissa Mitchell, Anne L. Theilmann, James A. Smart, Lindsey G. Hawke, Stephen D. Moore, Stephen J. Renaud, Michael J. Soares, Nicholas W. Morrell, Mark L. Ormiston
Summary: This study reveals that BMPR2 deficiency leads to NK cell impairment and pulmonary vascular disease, with the loss of IL-15 signaling as a contributing factor.
Article
Biology
Tatyana Novoyatleva, Nabham Rai, Baktybek Kojonazarov, Swathi Veeroju, Isabel Ben-Batalla, Paola Caruso, Mazen Shihan, Nadine Presser, Elsa Goetz, Carina Lepper, Sebastian Herpel, Gregoire Manaud, Frederic Perros, Henning Gall, Hossein Ardeschir Ghofrani, Norbert Weissmann, Friedrich Grimminger, John Wharton, Martin Wilkins, Paul D. Upton, Sonja Loges, Nicholas W. Morrell, Werner Seeger, Ralph T. Schermuly
Summary: The study by Novoyatleva et al investigates the role of receptor tyrosine kinase Axl in Pulmonary arterial hypertension (PAH), finding that the small molecule inhibitor R428 reduces human pulmonary arterial smooth muscle cells proliferation and migration, but causes toxicity in human pulmonary arterial endothelial cells. They further show that Axl enhances endothelial BMPR2 signaling, providing insights into mechanisms of PAH.
COMMUNICATIONS BIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Lingli Wang, Jan-Renier Moonen, Aiqin Cao, Sarasa Isobe, Caiyun G. G. Li, Nancy F. F. Tojais, Shalina Taylor, David P. P. Marciano, Pin-I. Chen, Mingxia Gu, Dan Li, Rebecca L. L. Harper, Nesrine El-Bizri, Yu-Mee Kim, Kryn Stankunas, Marlene Rabinovitch
Summary: This study found that the lack of BMPR2 is related to the abnormal phenotype of pulmonary artery smooth muscle cells (PASMC) in pulmonary arterial hypertension (PAH). Restoring normal signaling by reducing ARRB2 can reverse the hypocontractile and hyperproliferative phenotype of PASMC. Therefore, agents that neutralize ARRB2 may be able to prevent or reverse the aberrant phenotype of PASMC in PAH.
CIRCULATION RESEARCH
(2023)
Review
Cardiac & Cardiovascular Systems
Benjamin J. Dunmore, Rowena J. Jones, Mark R. Toshner, Paul D. Upton, Nicholas W. Morrell
Summary: PAH, a rare disease affecting 10 to 50 per million worldwide, lacks a cure and needs treatments to target key regulators of cellular pathology. Current therapies focus on vasoconstriction inhibition instead of addressing the root causes of the disease.
CARDIOVASCULAR RESEARCH
(2021)
Review
Biochemistry & Molecular Biology
Jamie L. Archambault, Cassidy A. Delaney
Summary: This article discusses the impact of 5-HT on fetal and neonatal pulmonary circulation and summarizes the existing preclinical and clinical literature on 5-HT in neonatal PH.
Article
Biochemistry & Molecular Biology
Norah Alruwaili, Sharath Kandhi, Ghezal Froogh, Melissa R. Kelly, Dong Sun, Michael S. Wolin
Summary: This study reveals that superoxide increases MMP9 expression, leading to the depletion of BMPR2 and promoting the development of pulmonary hypertension (PH). Knockout mice deficient in MMP9 show attenuated PH parameters and preserved COMP-dependent stabilization of BMPR2, suggesting a potential target for future therapies.
Article
Cell Biology
Md Khadem Ali, Xuefei Tian, Lan Zhao, Katharina Schimmel, Christopher J. Rhodes, Martin R. Wilkins, Mark R. Nicolls, Edda F. Spiekerkoetter
Summary: Bone morphogenic protein receptor 2 (BMPR2) expression and signaling are impaired in pulmonary arterial hypertension (PAH), and the mechanisms behind the decrease in BMPR2 signaling in PAH are poorly understood. This study identified protein tyrosine phosphatase 1B (PTPN1) as a novel regulator of BMPR2 signaling in pulmonary arterial endothelial cells (PAECs). PTPN1 was found to be downregulated in the blood of PAH patients and its downregulation was linked to endothelial dysfunction in PAECs. These findings provide insights into the molecular mechanisms involved in PAH and suggest a potential role for PTPN1 in the disease.
Article
Pharmacology & Pharmacy
Qian Jiang, Chunli Liu, Shiyun Liu, Wenju Lu, Yi Li, Xiaoyun Luo, Ran Ma, Chenting Zhang, Haixia Chen, Yuqin Chen, Zizhou Zhang, Cheng Hong, Wenliang Guo, Tao Wang, Kai Yang, Jian Wang
Summary: This study revealed that dysregulation of the BMP9/BMPR2/SMAD signaling pathway in pulmonary hypertension related to pulmonary fibrosis leads to severe loss of pulmonary arterial endothelium and vascular remodeling, contributing to the development of pulmonary hypertension. Therapeutic strategies that reinforce this signaling pathway may be ideal for this subtype of pulmonary hypertension.
BRITISH JOURNAL OF PHARMACOLOGY
(2021)
Article
Pediatrics
Wataru Takemori, Kenichiro Yamamura, Yoshitaka Tomita, Naoki Egami, Katsuhide Eguchi, Hazumu Nagata, Hiromitsu Shirouzu, Yuichi Ishikawa, Daisuke Nakajima, Akihiko Yoshizawa, Hiroshi Date, Shouichi Ohga
Summary: This study reported a case of a 29-month-old boy with PVOD and a novel BMPR2 gene variant associated with I/HPAH. This finding supports the concept that I/HPAH and PVOD are part of a spectrum of pulmonary vascular disease.
PEDIATRIC PULMONOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Malik Bisserier, Michael G. Katz, Carlos Bueno-Beti, Agnieszka Brojakowska, Shihong Zhang, Sarah Gubara, Erik Kohlbrenner, Shahood Fazal, Anthony Fargnoli, Peter Dorfmuller, Marc Humbert, Akiko Hata, David A. Goukassian, Yassine Sassi, Lahouaria Hadri
Summary: Pulmonary arterial hypertension (PAH) is a severe lung disease with high mortality rates. Research has shown that decreased SERCA2a expression in PAH patients is associated with down-regulation of BMPR2 and activation of STAT3. Combination therapy using SERCA2a gene transfer with a STAT3 inhibitor has shown promise in inhibiting PAH and restoring BMPR2 expression by limiting STAT3 activity.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Cardiac & Cardiovascular Systems
Malik Bisserier, Prabhu Mathiyalagan, Shihong Zhang, Firas Elmastour, Peter Dorfmuller, Marc Humbert, Gregory David, Sima Tarzami, Thomas Weber, Frederic Perros, Yassine Sassi, Susmita Sahoo, Lahouaria Hadri
Summary: This study investigated the role of SIN3a in the epigenetic mechanisms underlying hypermethylation of BMPR2 in PAH. Dysregulation of SIN3a expression was associated with decreased BMPR2 expression in patients and rodent models. SIN3a was found to regulate BMPR2 expression by preventing BMPR2 promoter methylation, and lung-targeted SIN3a gene therapy using adeno-associated virus serotype 1 showed promise as a therapeutic strategy for PAH.
Article
Respiratory System
Jane Chanda Kabwe, Hirofumi Sawada, Yoshihide Mitani, Hironori Oshita, Naoki Tsuboya, Erquan Zhang, Junko Maruyama, Yoshiki Miyasaka, Hideyoshi Ko, Kazunobu Oya, Hiromasa Ito, Noriko Yodoya, Shoichiro Otsuki, Hiroyuki Ohashi, Ryuji Okamoto, Kaoru Dohi, Yuhei Nishimura, Tomoji Mashimo, Masahiro Hirayama, Kazuo Maruyama
Summary: This study reveals that the Bmpr2 mutation in patients with pulmonary arterial hypertension exacerbates the clinical features of the disease and has significant effects on pulmonary vascular disease and survival rates in a rat model of pulmonary hypertension.
RESPIRATORY RESEARCH
(2022)
Review
Cardiac & Cardiovascular Systems
Marius Wits, Clarissa Becher, Frances de Man, Gonzalo Sanchez-Duffhues, Marie-Jose Goumans
Summary: This review explores the gender bias in pulmonary arterial hypertension (PAH) and investigates the gender differences in the TGF beta signaling family through mechanistic and translational evidence. Sex hormones and sex chromosome-related genetic processes can influence the function of the TGF beta signaling family.
CARDIOVASCULAR RESEARCH
(2023)
Article
Biochemistry & Molecular Biology
Afshan Dean, Teja Gregorc, Craig K. Docherty, Katie Y. Harvey, Margaret Nilsen, Nicholas W. Morrell, Margaret R. MacLean
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
(2018)
Article
Chemistry, Analytical
Nina Denver, Shazia Khan, Ioannis Stasinopoulos, Colin Church, Natalie Z. M. Homer, Margaret R. MacLean, Ruth Andrew
ANALYTICA CHIMICA ACTA
(2019)
Article
Respiratory System
Kirsty M. Mair, Katie Y. Harvey, Alasdair D. Henry, Dianne Z. Hillyard, Margaret Nilsen, Margaret R. MacLean
EUROPEAN RESPIRATORY JOURNAL
(2019)
Article
Cardiac & Cardiovascular Systems
Craig K. Docherty, Margaret Nilsen, Margaret R. MacLean
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2019)
Article
Biochemistry & Molecular Biology
Hicham Labazi, Julie Birkmose Axelsen, Dianne Hillyard, Margaret Nilsen, Asger Andersen, Margaret R. MacLean
Article
Medicine, Research & Experimental
Craig K. Docherty, Nina Denver, Simon Fisher, Margaret Nilsen, Dianne Hillyard, Rebecca L. Openshaw, Hicham Labazi, Margaret R. MacLean
MOLECULAR THERAPY-NUCLEIC ACIDS
(2020)
Article
Pharmacology & Pharmacy
Hicham Labazi, Margaret Nilsen, Margaret R. MacLean
Summary: Methamphetamine abuse is associated with the development of pulmonary arterial hypertension (PAH) and right ventricular failure, with female sex being a major risk factor for MA-induced PAH. The study found that methamphetamine caused right ventricular hypertrophy in female mice, but not in males, indicating a potential direct effect of MA on the right ventricle. This may help explain the poor outcomes observed in MA-associated female PAH patients.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Article
Peripheral Vascular Disease
Hannah E. Morris, Karla B. Neves, Margaret Nilsen, Augusto C. Montezano, Margaret R. MacLean, Rhian M. Touyz
Summary: This study found that Notch3 plays an important role in vascular diseases, particularly pulmonary arterial hypertension. It was discovered that increased activation of Notch3 leads to oxidative and endoplasmic reticulum stress, which in turn triggers redox signaling associated with procontractile pulmonary artery state, pulmonary vascular dysfunction, and the development of pulmonary arterial hypertension.
Article
Cardiac & Cardiovascular Systems
Geeshath Jayasekera, Kathryn S. Wilson, Hanna Buist, Rosemary Woodward, Aysel Uckan, Colin Hughes, Margaret Nilsen, A. Colin Church, Martin K. Johnson, Lindsay Gallagher, James Mullin, Mandy R. MacLean, William M. Holmes, Andrew J. Peacock, David J. Welsh
PULMONARY CIRCULATION
(2020)
Article
Multidisciplinary Sciences
Nina Denver, Shazia Khan, Ioannis Stasinopoulos, Colin Church, Natalie Z. M. Homer, Margaret R. MacLean, Ruth Andrew
Review
Cardiac & Cardiovascular Systems
Margaret (Mandy) R. MacLean
PULMONARY CIRCULATION
(2018)
Article
Hematology
Katie Y. Hood, Kirsty M. Mair, Adam P. Harvey, Augusto C. Montezano, Rhian M. Touyz, Margaret R. MacLean
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
(2017)